MiR-98 is involved in rat embryo implantation by targeting Bcl-xl  by Xia, Hong-Fei et al.
FEBS Letters 588 (2014) 574–583journal homepage: www.FEBSLetters .orgMiR-98 is involved in rat embryo implantation by targeting Bcl-xl0014-5793/$36.00  2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.12.026
Abbreviations: miRNAs, microRNAs; Bcl-xl, B-cell lymphoma-extra large;
30-UTR, 30-untranslated region; PFA, paraformaldehyde; BCIP, 5-bromo-4-chloro-
3-indolyl phosphate; NBT, p-nitroblue tetrazolium chloride; DIG, digoxigenin; ESCs,
endometrial stromal cells; FITC, ﬂuorescein isothiocyanate; PI, phosphatidylinosi-
tol; HRP, horseradish peroxidase
⇑ Corresponding author at: Genetic Center of National Research Institute for
Family Planning, Beijing 100081, China. Fax: +86 010 62179059.
E-mail addresses: hongfeixia@126.com (H.-F. Xia), genetic@263.net.cn (X. Ma).Hong-Fei Xia a,b, Xiao-Hua Jin a, Zong-Fu Cao a, Tian Shi c, Xu Ma a,b,⇑
aReproductive and Genetic Center of National Research Institute for Family Planning, Beijing 100081, China
bGraduate School, Peking Union Medical College, Beijing, China
cHaidian Maternal & Child Health Hospital, Beijing, China
a r t i c l e i n f oArticle history:
Received 15 September 2013
Revised 3 December 2013
Accepted 24 December 2013
Available online 18 January 2014
Edited by Tamas Dalmay
Keywords:
miR-98
Embryo implantation
Uterus
Rat
Bcl-xla b s t r a c t
In a previous study, via microRNA microarray analysis we found that miR-98 is differentially
expressed in rat uteri during the peri-implantation period (unpublished data). However, the role
of miR-98 in rat embryo implantation remains elusive. Here, we found that the level of miR-98 is
lower on day 5 and 6 of gestation (g.d. 5–6) than that on g.d. 3–4 and g.d. 7–8 in rat. MiR-98 expres-
sion is signiﬁcantly decreased by delayed implantation. Down-regulation of miR-98 promotes ESC
proliferation and inhibits apoptosis. Up-regulation of miR-98 displays opposite effects. Further
investigation revealed that miR-98 can bind to the 30-untranslated region (30-UTR) of B-cell
lymphoma-extra large (Bcl-xl) to inhibit Bcl-xl translation. Collectively, down-regulation of
miR-98 in rat uterus during the receptive phase is linked to the increase of cell proliferation via
targeting Bcl-xl.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Every successful pregnancy requires proper embryo implanta-
tion. Implantation involves an intricate discourse between the em-
bryo and the uterus and is a gateway to further embryonic
development. Although many molecules are now known to be in-
volved in the process, the speciﬁc mechanisms associated with the
successful embryo implantation remain elusive.
MicroRNAs (miRNAs) are endogenous 22 nucleotides non-
coding single-stranded RNAs that regulate gene expression by
blocking the translation or decreasing the stability of mRNAs [1].
Almost one-third of the protein-coding genes are susceptible to
miRNAs regulation [2]. Therefore, miRNAs play pivotal roles in
many biological processes, including cell proliferation, differentia-
tion, apoptosis and so on [3,4]. Our previous study had found that
miR-98was differentially expressed in rat uteri between the prere-
ceptive and receptive phase via miRNA microarray analysis
(unpublished data). Up to now, there are 49 articles to report the
function of miR-98, one half of these articles was about the roleof miR-98 in cancer. MiR-98 can inhibit prostate cancer growth
[5] and tumor angiogenesis and invasion by targeting activin
receptor-like kinase-4 and matrix metalloproteinase-11 [6]. MiR-
98 was aberrantly expressed during endometrial transition from
normal into cancerous states. The expression level of miR-98 was
low in endometrial tissues during the follicular and luteal phases
and the peri-postmenopausal period, and increased in all tumor
grades [7]. Embryo implantation shares the similar phenomena
and mechanisms with tumor development [8]. The differential
expression of miR-98 in rat uteri during the peri-implantation per-
iod displays that miR-98 may play a speciﬁcal role during rat em-
bryo implantation.
Here, we report the expression pattern of miR-98 in rat uterus
during the peri-implantation period and the effect of pseudopreg-
nancy, artiﬁcial decidualization, activation of delayed implantation
and hormone treatment on miR-98 expression. We also detect the
effect of miR-98 on cell growth and report the identiﬁcation of
B-cell lymphoma-extra large (Bcl-xl) gene as the target gene of
miR-98.
2. Materials and methods
2.1. Experimental animals and protocols
Sexually mature, healthy female Sprague Dawley rats
(220–260 g body weight) were purchased from the Laboratory
H.-F. Xia et al. / FEBS Letters 588 (2014) 574–583 575Animal Center of the Academy of Military Medical Sciences
(Beijing, China). Rats were housed in a temperature- and humid-
ity-controlled room with a 12/12 h light/dark cycle. All animal pro-
cedures were approved by the Institutional Animals Care and Use
Committee of the National Research Institute for Family Planning.
Rats were caged overnight with fertile males of the same strain.
The presence of a vaginal plug or sperm was considered as day 1
of pregnancy (g.d. 1). Uteri were collected from day 3 to day 8 of
pregnancy.
Pseudopregnancy was induced by caging adult females with
vasectomized males and mating was conﬁrmed by checking for a
vaginal plug (day 1 of pseudopregnancy). The uteri were collected
from day 3 to day 7 of pseudopregnancy. On day 5 of pseudopreg-
nancy, 100 ll olive oil (Sigma–Aldrich) was infused into the lumen
of one of the uterine horns to induce artiﬁcial decidualization. The
contralateral uterine horn, which was not infused with oil, served
as a control. On day 7 of pseudopregnancy, the rats were killed and
the uterine horns were isolated.
To induce delayed implantation, the pregnant rats on g.d. 4
were ovariectomized. Progesterone (5 mg/rat, s.c.; Sigma–Aldrich)
was injected intraperitoneally to maintain delayed implantation
from g.d. 5–7, and then the rats were treated with estradiol-17b
(0.5 lg/rat; Sigma–Aldrich) to terminate delayed implantation.
Uteri were collected at 24 h after estrogen treatment. To conﬁrm
that the rats receiving progesterone only were in a state of delayed
implantation, uterine ﬂushings were collected and examined for
the presence of hatched blastocysts. To conﬁrm that the delayed-
implantation rats treated with estradiol-17b terminated delayed
implantation and initiated embryo implantation, the implantation
sites were also identiﬁed by tail intravenous injection of Chicago
blue solution (Sigma–Aldrich). The implantation sites appeared
blue and the inter-implantation sites were colorless.
To test the effect of steroid hormones onmiR-98 expression, the
rats were ﬁrst ovariectomized. After 2 weeks, the ovariectomized
rats were injected with estradiol-17b (1 lg/rat) or progesterone
(10 mg/rat) at intervals of 24 h for 3 days. All steroids were dis-
solved in olive oil and injected intraperitoneally. Controls received
the vehicle only (0.1 ml/rat).
2.2. Northern blot analysis
40 lg of total RNAs per sample was subjected to electrophoresis
on a 15% urea-PAGE gel and transferred to a nylon membrane (Hy-
bond N+; Amersham Pharmacia). The membrane was hybridized
with 32P-labeled miR-98 probe (AACAATACAACTTACTACCTCA)
and U6 probe (CGTTCCAATTTTAGTATATGTGCTGCCGAAGCGA),
and then exposed to PhosphorImager screens (GE Healthcare). The
bands were analyzed using Quantity One software (Bio-Rad). All
experiments were repeated for at least three times.
2.3. TaqMan miRNA RT-real time PCR
Total RNAs were extracted from cells using Trizol (Invitrogen)
according to the manufacture’s instructions. Single-stranded cDNA
was synthesized using TaqMan MiRNA Reverse Transcription Kit
(Applied Biosystems) and then ampliﬁed using TaqMan Universal
PCR Master Mix (Applied Biosystems) together with miRNA-spe-
ciﬁc TaqMan MGB probe: miR-98 or U6 (Applied Biosystems). The
U6 snoRNA was used for normalization. Each sample in each group
was measured in triplicate and the experiment was repeated for at
least three times.
2.4. In situ hybridization
Sections of uterus (5 lm) were treated with proteinase K
(20 g/ml) and reﬁxed in 4% paraformaldehyde (PFA). Sections werehybridized with digoxigenin (DIG)-labeled LNA-miR-98 probe
(LNA-miR-98 sequence: 50-DIG-aAcaaTaCAaCttaCtAcCtCa-30), and
then incubated in buffer containing anti-DIG-antibody, followed
by staining with 5-bromo-4-chloro-3-indolyl phosphate (BCIP)
and p-nitroblue tetrazolium chloride (NBT) (Promega). The sec-
tions were hybridized with a DIG-labeled LNA-scrambled probe
(LNA-scrambled sequences: 50-caTtaAtgTcGgaCaaCtcAat-30) as a
negative control [9]. Sections were observed under an Eclipse 80i
microscope (Nikon).
2.5. Cell viability assay
In vitro cell viability was estimated with an MTS assay. Brieﬂy,
endometrial stromal cells (ESCs) isolated from rat uteri
(5000 cells/well) were seeded in 96-well plates (Corning), and
allowed to attach overnight. The cells were then transfected with
miR-98mimcs, pre-miR control,miR-98 inhibitor, anti-miR control,
PCA-Bcl-xl or miR-98 mimcs and PCA-Bcl-xl, respectively. 20 ll
MTT (5 mg/ml; Sigma–Aldrich) were added to each well 48 h after
transfection. Absorbance was recorded at A570 nm with a 96-well
plate reader (Bio-Rad 3550). Each treatment group was repeated 3
wells. The experiment was repeated for three times and the results
were described as a ratio of A570 nm with miR-98mimcs or inhib-
itor vs. corresponding control.
2.6. Flow cytometry analysis
Cells apoptosis was performed with ﬂow cytometry analysis by
Annexin V-FLUOS staining Kit (Roche). Every specimen was added
2.5 ll annexin V-ﬂuorescein isothiocyanate (FITC) stock and 5 ll
20 lg/ml phosphatidylinositol (PI) and then quantiﬁed by ﬂow
cytometry (BD Biosciences). Each treatment was repeated twice
within an experiment. The experiment was repeated for three
times.
2.7. Plasmid construction
To generate 30-untranslated region (UTR) luciferase reporter,
partial sequence of the 30-untranslated region (30-UTR) from
Bcl-xl was cloned into the downstream of ﬁreﬂy luciferase gene
in pGL3-Control Vector (Promega) using the primers (Forward/
SpeI: GCGACTAGTAGAGCCATTGAGTGAGGTGC; Reverse/XbaI: TCG
TCTAGAGGCATTCTGACCTTGGCAGC). Deleting miR-98 target sites
in the 30-UTR of Bcl-xl was used as control.
The coding region of Bcl-xl sequence was ampliﬁed by RT-PCR
from total mRNA of rat uterus using the primers (Forward/XbaI:
AGCTCTAGAATGTCTCAGAGCAACCGGGA; Reverse/SacI: ATAGAGCT
CTCACTTCCGACTGAAGAGTG. After being double digested with Xba
I and Sac I, the PCR product was cloned into PCAGGS-IRES-EGFP
(PCA) control vector, designated PCA-Bcl-xl. All the constructs
were veriﬁed by DNA sequencing.
2.8. Dual-luciferase activity assay
HEC-1B cells were seeded in 48-well plates and allowed to
attach overnight, then transfected with 50 nM of the miR-98
mimics, miR-98 inhibitor, pre-miR control or anti-miR control
(GenePharm) using lipofectamine 2000 (Invitrogen). HEC-1B cells
were also transfected with wild-type or mutant reporter plas-
mid. pRL-TK containing Renilla luciferase was co-transfected for
data normalization. 2 days later, cells were harvested and as-
sayed with the dual-luciferase assay (Promega). Each treatment
was performed in triplicate in three independent experiments.
The results were expressed as relative luciferase activity (Fireﬂy
LUC/Renilla LUC).
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60 lg of cell protein lysates was loaded into each lane of 12%
polyacrylamide gels. The proteins were separated by electrophore-
sis and transferred to polyvinylidene ﬂuoride membrane (PVDF)
(Amersham Pharmacia) by electrophoretic transfer. The mem-
branes were incubated with rabbit anti-BCL-XL or -b-ACTIN poly-
clonal antibody (Santa Cruz Biotechnology). Detection was
carried using the ECL kit (Millipore). The b-ACTIN was used as a
loading control. The experiment was repeated for at least threeFig. 1. Changes in uterine miR-98 level during early pregnancy. (A) The expression of miR
snRNA was used as loading control to normalize for gel loading and transfer. The histogra
a ratio ofmiR-98 to U6 intensity. (B) The expression ofmiR-98 in the endometrium betwe
detected by TaqMan miRNA RT-real time PCR. U6 serves as an internal reference. The etimes. The bands were analyzed using Quantity One analyzing sys-
tem (Bio-Rad).
2.10. Statistical analysis
All values are reported as the mean ± SEM. Statistical analysis
was done using one-way ANOVA. When signiﬁcant effect of treat-
ments were indicated, the Student–Newman–Keuls multi-range
test was applied using SPSS version 13.0. P < 0.05 was considered
statistically signiﬁcant.-98 in rat uteri from day 3 to day 8 of pregnancy was detected by Northern blot. U6
m represents themiR-98 level quantiﬁed by densitometric analysis and expressed as
en the implantation sites and the inter-implantation sites on day 6 of pregnancy was
xpression of miR-98 in the inter-implantation sites was set to 1 ⁄P < 0.05.
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3.1. MiR-98 expression and regulation in rat uterus during early
pregnancy
In this study, we ﬁrst examined the temporal and spatial distri-
bution of miR-98 in rat uterus during the peri-implantation period.
Northern blot analysis showed that the expression level of miR-98
on g.d. 5–6 was lower than on g.d. 3–4 and g.d. 7–8 (P < 0.05;
Fig. 1A). In addition, we also detected the expression of miR-98 in
the endometrium between the implantation sites and the inter-
implantation sites on day 6 of pregnancy by TaqMan miRNA
RT-real time PCR. The miR-98 level was higher in the inter-implan-
tation sites than that in the implantation sites (P < 0.05; Fig. 1B).
To ﬁnd out whether miR-98 expression was dependent on the
presence of embryos, the expression of miR-98 in uterine tissues
from day 3 to day 7 of pseudopregnancy was subjected to NorthernFig. 2. MiR-98 expression in rat uteri in the model of pseudopregnancy, delayed-imp
represents the miR-98 level. U6 snRNA was used as loading control ⁄P < 0.05.blot (Fig. 2A). There was no signiﬁcant difference in the expression
level of miR-98 from day 3 to day 7 of pseudopregnancy.
To test whether miR-98 expression was dependent upon em-
bryo implantation status, a delayed implantation model was used
for Northern blot analysis. The miR-98 level was decreased after
implantation was activated with estrogen treatment compared
with the untreated group (P < 0.05; Fig. 2B).
To test whether miR-98 expression was regulated by decidual-
ization, a model of experimentally induced decidualization was
used for Northern blot analysis. The miR-98 level in the decidual-
ized uterus was similar with that in the non-stimulated uterus
on day 7 of pseudopregnancy (Fig. 2C).
3.2. Effect of steroid hormones on miR-98 expression
WhethermiR-98 expression was regulated by steroid hormones
under physiological conditions was examined by Northern blot.lantation and artiﬁcal decidualization detected by Northern blot. The histogram
Fig. 3. The effect of steroid hormones on uterine miR-98 expression detected by
Northern blot. U6 snRNA was used as loading control. The histogram represents the
miR-98 level ⁄P < 0.05.
Fig. 4. In situ localization ofmiR-98 in rat uteri. Uteri sections from Day 4 (A), Day 5 (B), D
of delayed implantation (F), the non-stimulated (G) and stimulated (H) of artiﬁcial dec
probe. Negative control staining was performed using DIG-labeled LNA-scrambled prob
100 original magniﬁcation. Key: m, myometrium; mg, maternal gland; s, stroma; le, lum
sdz, secondary decidual zone.
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mized non-pregnant rat. Progesterone treatment did not affect the
expression of miR-98. However, treatment with estradiol-17b or
both estradiol-17b and progesterone signiﬁcantly decreased the
miR-98 level (P < 0.05; Fig. 3).
3.3. Localization of miR-98 in rat uterus
Localization of miR-98 in rat uterus during early pregnancy was
detected by in situ hybridization.MiR-98 was mainly located in the
glandular and luminal epithelia, superﬁcial and deep stroma on
g.d. 4 (Fig. 4A). On g.d. 5, miR-98 signals were weakened in the
luminal epithelia and superﬁcial stroma (Fig. 4B). On g.d. 6, strong
miR-98 signals were found in the primary decidual zone. The miR-
98 staining was attenuated in the secondary decidual zone and
luminal epithelia (Fig. 4C). In the model of activation of delayed
implantation, strongmiR-98 signals were detected in the glandular
epithelia in untreated group (Fig. 4D). Intense staining of miR-98
was mainly found in the glandular and luminal epithelia, and weak
staining in the superﬁcial and deep stroma in the group treated
with progesterone alone (Fig. 4E). After activation of delayed
implantation by injection of estradiol-17b, miR-98 signals were
attenuated in the glandular and luminal epithelia (Fig. 4F). In the
model of artiﬁcial decidualization, strong staining was found in
the glandular and luminal epithelia, superﬁcial and deep stroma
in the control uterine horn (Fig. 4G). However, in the oil-infused6 (C) of pregnancy, the untreated group (D), delayed implantation (E) and activation
idualization were subjected to in situ hybridization using DIG-labeled LNA-miR-98
e (I). Blue staining indicates hybridization signals. The photographs were shown at
inal epithelium; ss, superﬁcial stroma; ds, deep stroma; pdz, primary decidual zone;
H.-F. Xia et al. / FEBS Letters 588 (2014) 574–583 579uterus, miR-98 signals were mainly detected in the primary decid-
ual zone (Fig. 6H).
3.4. The effect of miR-98 on cell proliferation and apoptosis
ESCs were transfected withmiR-98mimics or inhibitor to detect
the change of cell proliferation by MTS assay (Fig. 5A). The relative
proliferation rates in ESCs transfected with miR-98 mimics were
signiﬁcantly decreased compared with the pre-miR control
(P < 0.05). The relative proliferation rates in cells transfected with
miR-98 inhibitor was obviously increased compared with the
anti-miR control (P < 0.05).
To further explore the role of miR-98 in controlling cell growth,
apoptosis in ESCs were determined by ﬂow cytometry analysis
(Fig. 5B). Transfection with miR-98 mimics increased the number
of early (4.99% vs. 2.01%) and late apoptotic cells (8.34% vs.
5.40%) compared to the pre-miR control. When cells wereFig. 5. The effect of miR-98 on ESCs proliferation and apoptosis. ESCs were transfecte
respectively. Cell proliferation was determined byMTS assay (A). Cell apoptosis was deter
FITC positive and PI negative); upper right quadrant, late apoptosis/necrosis cells (annetransfected bymiR-98 inhibitor, the number of early apoptotic cells
is slightly lower than that in control group (1.24% vs. 2.33%), and
the number of late apoptotic cells was visibly decreased compared
to the anti-miR control (4.71% vs. 6.24%).
3.5. Prediction and conﬁrmation of the target gene of miR-98
To analyze the molecular mechanisms in whichmiR-98were in-
volved, we looked for its target gene. An online search of miR-98
targets by miRanda (http://www.cbio.mskcc.org/cgi-bin/mirnaviewer/
mirnaviewer.pl, [10] and TargetScan databases (http://www.genes.
mit.edu/targetscan.test/ucsc.html, [11]) provided a large number
of putative mRNA targets. Among them, we focused on Bcl-xl for
the following reasons: (i) TargetScan and miRanda prediction
showed that there was one conservative miR-98 responsive
element in 30-UTR of Bcl-xl (Fig. 6A), and (ii) it was reported that
Bcl-xl was involved in cell growth [12,13].d with the pre-miR control, miR-98 mimics, anti-miR control or miR-98 inhibitor,
mined by ﬂow cytometry (B). Lower right quadrant, early apoptotic cells (annexin V-
xin V-FITC and PI positive) ⁄P < 0.05.
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reporter assay. The 30-UTR fragment of wild-type Bcl-xl containing
the binding sites of miR-98 was cloned into the downstream ofFig. 6. The prediction and conﬁrmation of the miR-98 target in rat. (A) MiR-98 binding
fragment of wild-type Bcl-xl containing the binding sites of miR-98 was cloned into pGL3
miR-98mimics,miR-98 inhibitor, pre-miR control or anti-miR control, and wt-Bcl-xl for du
xl (designated as del-Bcl-xl) was used as control. HEC-1B cells were co-transfected with
luciferase was co-transfected for data normalization ⁄⁄P < 0.01.ﬁreﬂy luciferase reporter gene in pGL3 control vector (designated
as wt-Bcl-xl) for the dual-luciferase assay (Fig. 6B). HEC-1B cells
were co-transfected with wt-Bcl-xl andmiR-98mimics or inhibitorsites in the 30-UTR region of Bcl-xl was compared in cross-species. (B) The 30-UTR
control vector (designated as wt-Bcl-xl). (C) HEC-1B cells were co-transfected with
al-luciferase assay. (D) Deleting putativemiR-98 binding region in the 30-UTR of Bcl-
miR-98 and wt- or del-Bcl-xl for dual-luciferase assay. pRL-TK containing Renilla
Fig. 8. Overexpression of Bcl-xl partially restored the inhibition of cell growth
induced by up-regulation of miR-98. Cell proliferation was determined by MTS
assay ⁄P < 0.05.
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ity in cells co-transfected with miR-98 mimics and wt-Bcl-xl was
decreased about 69.06% (P < 0.01). Furthermore, in cells co-trans-
fected with miR-98 inhibitor and wt-Bcl-xl, the luciferase activity
was up-regulated about 44.19% (P < 0.01) compared with the
anti-miR control.
Base deletion of seed sequence was also conducted to further
conﬁrm the binding sites for miR-98 (Fig. 6D). Deleting putative
miR-98 binding region in the 30-UTR of Bcl-xl (designated as del-
Bcl-xl) was used as control. The histogram in Fig. 6D showed that
the enzyme activity was reduced about 39.16% in cells co-transfec-
ted with miR-98 mimics and wt-Bcl-xl compared with del-Bcl-xl
(P < 0.01).
3.6. MiR-98 regulates BCL-XL expression
To ascertain whether miR-98 regulates endogenous BCL-XL
expression, we transfected HEC-1B cells with miR-98 mimics or
inhibitor to detect the change of BCL-XL by Western blot (Fig. 7).
Compared with the pre-miR control, BCL-XL protein level was sig-
niﬁcantly down-regulated bymiR-98mimics (P < 0.05). In addition,
compared with the anti-miR control, BCL-XL protein level was
measurably up-regulated by miR-98 inhibitor (P < 0.05).
3.7. Bcl-xl overexpression partially restore the suppression of cell
growth induced by miR-98
To further test whether miR-98 may execute cells suppressive
function by targeting Bcl-xl, we investigated the effect of Bcl-xl on
miR-98-mediated cell growth suppression (Fig. 8). The relative
proliferation rates in ESCs transfected with Bcl-xl expression vector
PCA-Bcl-xl were signiﬁcantly increased compared with PCA empty
vector control (P < 0.05). MiR-98 mimics markedly reduced the
relative proliferation rates in ESCs (P < 0.05). When cells were
co-transfected with miR-98 mimics and PCA-Bcl-xl, the relative
proliferation rates were higher than transfection of miR-98 mimicsFig. 7. Detection of the effect ofmiR-98 on endogenous BCL-XL expression. BCL-XL protei
Western blot. b-ACTIN was used as loading control ⁄P < 0.05.(P < 0.05) and close to the pre-miR control and PCA control. These
results imply that miR-98 overexpression-mediated the suppres-
sion of cell growth is partially rehabilitated by the up-regulation
of Bcl-xl.
4. Discussion
To our knowledge, this is the ﬁrst report of the expression and
regulation of the miR-98 during rat embryo implantation. To study
the role of miR-98 in embryo implantation, we ﬁrst examined its
temporal and spatial distribution in rat uterus during the peri-
implantation period. The expression of miR-98 in rat uterus on
g.d. 5–6 was lower than that on g.d. 3–4 and g.d. 7–8, and it mainly
found in the glandular and luminal epithelia and stroma/decidua.
Rat blastocysts can implant only if the endometrium has been in-
duced a transient state of endometrial receptivity to embryon level inmiR-98mimics (A) and inhibitor (B) -treated HEC-1B cells was detected by
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tivity for embryo implantation in rat occurred on day 5 of preg-
nancy. In response to implanting embryos the underlying
endometrial stromal cells undergo decidualization [14]. The tem-
poral and spatial distribution of miR-98 during early pregnancy
suggests that the state of endometrial receptivity may suppress
the expression of miR-98.
To further explore whether miR-98 expression was associated
with the induction of implantation, we measured the effect of
pseudopregnancy, delayed implantation and experimentally in-
duced decidualization on miR-98 expression. We found that the
miR-98 level was not signiﬁcant different in rat uterus during day
3 to day 7 of pseudopregnancy. The expression of miR-98 was de-
creased after estrogen treatment induced blastocyst activation for
implantation. Embryo transfer experiments have revealed that rat
blastocysts transferred to the uterine lumen of day 4.5 pseudo-
pregnant recipients remain in a state of dormancy until the endo-
metrium becomes receptive on day 5, then embryo implantation
can be initiated on day 5.5 [14,15]. This phenomenon implies that
the activated blastocysts may to be one of the major contributors
to the regulation of miR-98. In the model of artiﬁcial decidualiza-
tion, the expression level of miR-98 was not signiﬁcant different
between the non-stimulated and stimulated uterus. These results
indicate that the decrease in miR-98 level may be not dependent
upon endometrial decidualization.
Under pregnant conditions, ovarian progesterone and estrogen
are essential for embryo implantation in mice and rats [16]. Under
physiological conditions, ovarian progesterone and estrogen are
necessary to simulate endometrial milieu of a fertile menstrual cy-
cle. But it is still unclear whether progesterone and estrogen affect
miR-98 expression under physiological conditions. In the study, we
found that miR-98 expression was signiﬁcantly down-regulated by
administration of estradiol-17b or both estradiol-17b and proges-
terone in the ovariectomized non-pregnant rat uterus. These re-
sults implies that the low expression of miR-98 may be beneﬁt to
the maintenance of female endocrine homeostasis under physio-
logical conditions. In addition, progesterone treatment did not
signiﬁcantly affect the expression of miR-98 in the uterus of the
ovariectomized non-pregnant rat. However, miR-98 expression
showed a decreasing trend in the uterus of the ovariectomized
pregnant rat treated by progesterone. It is different in gene expres-
sion patterns and hormonal levels in rat uterus between pregnancy
and non-pregnancy [17,18], which may be one of the reasons that
results in the contradictory results.
To explore the possible function of miR-98 in rat embryo
implantation, we detected the effect of miR-98 on the growth of
ESCs. Up-regulation of miR-98 inhibited cell proliferation and pro-
moted cell apoptosis in ESCs. Down-regulation of miR-98 acceler-
ated cell proliferation and inhibited cell apoptosis. The
conclusion was similar with Ting et al’s report that miR-98 inhib-
ited prostate cancer growth [5]. Therefore, the down-regulation
of miR-98 in rat uteri during the receptive phase may contribute
to uterine reconstruction to establish a healthy pregnancy.
To analyze the possible molecular mechanisms by which miR-
98 affected cell viability, we studied its target gene. It was well
known that the Bcl-2 family proteins were involved in the regula-
tion of cell apoptosis and divided in two main groups of proteins,
antiapoptotic or proapoptotic [19]. An online search of miR-98 tar-
gets by miRanda and TargetScan showed that there was one con-
servative miR-98 responsive element in 30-UTR of Bcl-xl, one of
the antiapoptotic members of Bcl-2 family. In the luciferase assay
of transfection with wt-Bcl-xl, luciferase activity was down-regu-
lated bymiR-98mimics and up-regulated bymiR-98 inhibitor, sug-
gesting that the abnormal expression of miR-98 affected the
binding of miR-98 and 30-UTR of Bcl-xl. Our deletion experiment
conﬁrmed that the binding sites in the 30-UTR of Bcl-xl werespeciﬁc for miR-98. In addition, miR-98 reversely regulated
BCL-XL protein level. These data show that Bcl-xl is the target gene
of miR-98. Bcl-xl had been shown to block apoptosis induced by a
variety of stimuli and to be a stronger protector against apoptosis
than Bcl-2 under certain circumstances [20]. Bcl-xl was capable of
preventing cytochrome c release while signiﬁcantly inhibiting cell
death [21]. Therefore, the up-regulation of Bcl-xl by the decrease of
miR-98 may contribute to prevent uterine cell excessive apoptosis
and facilitate proper embryo implantation.
In conclusion, we found that miR-98 expression was down-reg-
ulated in rat uterus during the receptive phase and regulated by
blastocysts activation. Enforced miR-98 expression promoted ESCs
apoptosis, which was partially through regulating anti-apoptotic
factors Bcl-xl. This study may have the potential to provide new in-
sights into the mechanisms of embryo implantation.
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